Comparing Skyrizi and Tremfya for Psoriasis Care
Plaque psoriasis, a chronic autoimmune condition, presents treatment challenges addressed by biologic drugs like Skyrizi and Tremfya. Both target Interleukin-23, alleviating symptoms through distinct dosing regimens. Reviewing efficacy, potential side effects, and personalized considerations is crucial. Emerging trends, such as combination therapies and biosimilars, could reshape patient access and treatment outcomes. Understanding Psoriasis Treatment: Skyrizi […]
3 minute read